Hill Rom (US) is one of the leading players in Spirometers Market

The spirometers market is expected to reach USD 1,047 million by 2023 from USD 655 million in 2018, at a CAGR of 9.8%. Market growth is largely driven by the rising global incidence of respiratory diseases, global population, and technological advancements in spirometer devices. Opportunities for growth of the market exist in emerging economies on account of increasing pollution levels and rising awareness regarding COPD and other respiratory conditions. On the other hand, the time required to carry out tests using spirometers and data accuracy issues associated with personalized spirometers are expected to limit market growth during the forecast period.

The spirometers market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (UK), and MidMark Corporation (US).

The key strategies followed by most companies in the spirometers market are product launches and partnerships. These two strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.

Hill-Rom is the largest player in the spirometers market. The company focuses on the development of devices, consumables, accessories, and software required to perform spirometer tests. These products are sold under the brand Welch Allyn. The company also invests a significant amount on research and development activities. In 2018, it spent ~5% of its revenue on R&D activities. The company has a global presence through its own subsidiaries as well as a network of distributors. Hill Rom has become a key player in the spirometers market after its acquisition of Welch Allyn.